← Back to patent-cliff list
CAS 111-45-5
2-[(Prop-2-en-1-yl)oxy]ethan-1-ol
Codes：(I)101438-79-a
Application context (from source-drug indications)
乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-[(Prop-2-en-1-yl)oxy]ethan-1-ol→1-Phenyltetrazoline-5-thione→1-Phenyl-5-([2-[(prop-2-en-1-yl)oxy]ethyl]sulfanyl)-1H-tetrazole→1-Phenyl-5-[2-[(prop-2-en-1-yl)oxy]ethanesulfonyl]-1H-tetrazole→(1R*)-2-[(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]-1-methylcyclohex-2-ene-1-carbaldehyde→(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-4-[(6S*)-6-methyl-6-[3-[(prop-2-en-1-yl)oxy]prop-1-en-1-yl]cyclohex-1-en-1-yl]-1,3-dioxaspiro[4.5]dec-7-en-2-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.